Observational studyHeart and vessels2020

Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Woohyeun Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.